Bone Biologics (BBLG) vs CollPlant Biotechnologies (CLGN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
CollPlant Biotechnologies is the larger company by market cap ($7.5 million vs $1.3 million), about 5.8 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | BBLG | CLGN |
|---|---|---|
| Share price | $0.4691 | $3.97 |
| Market cap | $1.29M | $7.51M |
| 1-day change | -3.77% | +14.74% |
| EPS (TTM) | $-1.37 | $-9.33 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.79 | $26.80 |
| 52-week low | $0.428 | $2.64 |
| Distance from 52-week high | -83.19% | -85.19% |
| Analyst consensus | none | — |
| Avg. price target upside | +2500.72% | — |
| Average volume | 378.57K | 351.98K |
| Shares outstanding | 2.76M | 1.89M |
| Employees | 2 | 39 |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CollPlant Biotechnologies is about 5.8 times larger than Bone Biologics by market value ($7.51M vs $1.29M).
About Bone Biologics
BBLG stock →Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein in the United States. Its lead product is NELL-1/DBM medical device, an osteopromotive recombinant protein, which provides target specific control over bone regeneration.
Healthcare · Biotechnology · 2 employees
About CollPlant Biotechnologies
CLGN stock →CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, Israel, Europe, and internationally. Its products are based on its recombinant human collagen (rhCollagen) that is produced using its proprietary technology.
Healthcare · Biotechnology · 39 employees
BBLG vs CLGN FAQ
Which is bigger, Bone Biologics or CollPlant Biotechnologies?
CollPlant Biotechnologies (CLGN) is larger, with a market capitalization of $7.51M compared with $1.29M for Bone Biologics (BBLG).
Are Bone Biologics and CollPlant Biotechnologies in the same industry?
Yes. Both are classified in the Biotechnology industry within the Healthcare sector.